Tradestie Institutional Equity Comparison Engine
FBT vs BBP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FBT Overall Edge
FBT Captures Institutional Edge (1โ0 Pillars ยท 2โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to First Trust NYSE Arca Biotechnology Index Fund (FBT) driven by superior Momentum & Technical. Fundamentally, FBT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BBP at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, FBT sits in UNCLASSIFIED (4th %ile IV; Dealer Gamma Walls on Pro) against BBP sits in UNCLASSIFIED (4th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
FBT N/M vs BBP N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
FBT
1Y +33.7% vs +30.1% ยท 52W Pos 83% vs 70%
Options & Structure Winner
Tie
UNCLASSIFIED (4th %ile IV) vs UNCLASSIFIED (4th %ile IV)
FBT
NYSE Arca
First Trust NYSE Arca Biotechnology Index Fund
Institutional Equity
$266.97
-1.5% 1D
Market Cap
N/A
1M Return
+1.28%
1Y Return
+33.69%
Forward P/E
N/M
Unified AI Score
53.1 / 100
HOLD
Tech 45.0
Fund 45.0
Flow 50.0
Mom 41.1
BBP
NYSE Arca
Virtus LifeSci Biotech Products ETF
Institutional Equity
$99.30
-2.67% 1D
Market Cap
N/A
1M Return
-0.9%
1Y Return
+30.13%
Forward P/E
N/M
Unified AI Score
53.0 / 100
HOLD
Tech 37.0
Fund 48.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FBT +33.69%
BBP +30.13%
Spread: +3.56 pp (FBT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
FBT TTM Op. Margin: N/A
BBP TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FBT vs BBP. Trailing 12-month operating profitability (FBT N/A vs BBP N/A) and valuation multiples (FBT N/M vs BBP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FBT | BBP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 83% ($189โ$283) | 70% ($74โ$110) | Stronger Trend | FBT |
| Beta / 30D Volatility Risk Regime | 0.79ฮฒ ยท 27% Vol | 0.94ฮฒ ยท 30% Vol | Lower Realized Risk | FBT |
| Unified Institutional Score Composite Signal | 53.1 / 100 (HOLD) | 53.0 / 100 (HOLD) | Higher Composite | Tie |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FBT vs BBP Buy Guide
FBT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
BBP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FBT nor BBP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.